Fort Point Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,299
| Closed | -$481K | – | 300 |
|
|
2021
Q4 | $481K | Sell |
4,299
-198
| -4% | -$22.2K | 0.06% | 162 |
|
|
2021
Q3 | $565K | Sell |
4,497
-83
| -2% | -$10.4K | 0.08% | 120 |
|
|
2021
Q2 | $620K | Buy |
4,580
+77
| +2% | +$10.4K | 0.11% | 78 |
|
|
2021
Q1 | $611K | Sell |
4,503
-526
| -10% | -$71.4K | 0.13% | 72 |
|
|
2020
Q4 | $708K | Sell |
5,029
-54
| -1% | -$7.6K | 0.16% | 68 |
|
|
2020
Q3 | $566K | Buy |
+5,083
| New | +$566K | 0.14% | 70 |
|